keyword
https://read.qxmd.com/read/38597210/gender-affirming-hormone-therapy-and-cardiovascular-health-in-transgender-adults
#21
REVIEW
Caroline Ong, Monique Monita, Minghao Liu
A growing number of people identify as transgender and gender non-binary in the USA and worldwide. Concomitantly, an increasing number of patients are receiving gender-affirming hormone therapy (GAHT) to achieve gender congruence. GAHT has far-ranging effects on clinical and subclinical markers of cardiovascular risk. Transgender patients also appear to be at higher risk for cardiovascular diseases compared to their cisgender peers and the impact of gender-affirming therapy on cardiovascular health is unclear...
April 10, 2024: Climacteric: the Journal of the International Menopause Society
https://read.qxmd.com/read/38593634/reproductive-factors-and-risk-of-physical-frailty-among-chinese-women-living-in-singapore
#22
JOURNAL ARTICLE
Vanda W T Ho, Kevin Yiqiang Chua, Xingyue Song, Aizhen Jin, Woon-Puay Koh
SETTING: Although age at menopause has been linked to higher risk of physical frailty in later life, little is known about other reproductive factors. OBJECTIVES: Our study aimed to investigate the associations between 1) age at menarche, 2) age at natural menopause, 3) duration of reproductive period, 4) number of children, 5) use of oral contraceptives (OCP), and 6) use of hormone replacement therapy (HRT) with the risk of physical frailty in late life. DESIGN: We used data from 5934 women of the Singapore Chinese Health Study who experienced natural menopause, and participated in the third follow-up interviews when physical frailty was assessed...
April 8, 2024: Journal of Nutrition, Health & Aging
https://read.qxmd.com/read/38592285/hormone-replacement-therapy-in-post-menopause-hormone-dependent-gynecological-cancer-patients-a-narrative-review
#23
REVIEW
Paola Villa, Valentina Elisabetta Bounous, Inbal Dona Amar, Federica Bernardini, Margherita Giorgi, Daniela Attianese, Annamaria Ferrero, Marika D'Oria, Giovanni Scambia
BACKGROUND: Advances in the treatment of gynecological cancer have led to improvements in survival but also an increase in menopausal symptoms, especially in young women with premature iatrogenic menopause. METHODS: A narrative review was performed to clarify the possibility of prescribing hormone replacement therapy (HRT) after hormone-dependent gynecological cancers (ovarian cancer [OC], cervical adenocarcinoma [AC], and endometrial cancer [EC]). RESULTS: HRT can be prescribed to patients with early-stage, grade I-II OC who experience bothersome menopausal symptoms non-responsive to alternative non-hormone therapy after optimal surgery...
March 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38592079/role-of-female-sex-hormones-in-adpkd-progression-and-a-personalized-approach-to-contraception-and-hormonal-therapy
#24
REVIEW
Micaela Petrone, Martina Catania, Liliana Italia De Rosa, Rebecca S Degliuomini, Kristiana Kola, Chiara Lupi, Matteo Brambilla Pisoni, Stefano Salvatore, Massimo Candiani, Giuseppe Vezzoli, Maria Teresa Sciarrone Alibrandi
This review navigates the intricate relationship between gender, hormonal influences, and the progression of autosomal dominant polycystic kidney disease (ADPKD), highlighting the limited literature on this crucial topic. The study explores the impact of female sex hormones on liver and renal manifestations, uncovering gender-specific differences in disease progression. Actually, hormonal therapy in women with ADPKD remains a challenging issue and is a source of concern regarding its potential impact on disease outcomes, particularly at the hepatic level...
February 22, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591925/perineural-5-dextrose-versus-corticosteroid-injection-in-non-surgical-carpal-tunnel-syndrom-treatment
#25
JOURNAL ARTICLE
Ocek Ozge, Guner Derya
BACKGROUND AND PURPOSE: <p>We aimed to investigate the difference of clinical and electrophysiological improvement between perineural corticosteroid injection therapy (PCIT) and perineural 5% dextrose injection therapy (5%PDIT) in carpal tunnel syndrome (CTS).</p>. METHODS: <p>Total of 92 wrists that were diagnosed as mild-to-moderate idiopathic CTS and completed their follow-up were included in our study. The severity of pain, symptom severity and functional status were asses&shy;sed by visual analog scale (VAS) and the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) scores for treatment effectiveness...
March 30, 2024: Ideggyógyászati Szemle
https://read.qxmd.com/read/38586692/a-case-report-of-a-metastatic-papillary-carcinoma-of-the-thyroid
#26
Abhilasha Bhargava, Chandrashekhar Mahakalkar, Shivani Kshirsagar, Shivani Bothara, Jayashree Bhawani
Neck lumps can be a symptom of thyroid and parathyroid gland metabolic diseases, and papillary thyroid carcinoma is reported in some cases. It is commonly observed in middle-aged people with a female predominance. Papillary carcinoma of the thyroid is the most common type of thyroid cancer, originating from the thyroid gland cells. It is slow-growing and less aggressive, but it has been reported to have the ability to affect nearby lymph nodes and other organs. It is associated with the RET protooncogene, NTRK1, and MET genes...
March 2024: Curēus
https://read.qxmd.com/read/38584466/cell-membrane-coated-nanoparticles-cutting-edge-drug-delivery-systems-for-osteoporosis-therapy
#27
REVIEW
Jiewen Liao, Li Lu, Xiangyu Chu, Yuan Xiong, Wu Zhou, Faqi Cao, Peng Cheng, Mohammad-Ali Shahbazi, Guohui Liu, Bobin Mi
Osteoporosis, characterized by a reduction in bone mineral density, represents a prevalent skeletal disorder with substantial global health implications. Conventional therapeutic strategies, exemplified by bisphosphonates and hormone replacement regimens, though effective, encounter inherent limitations and challenges. Recent years have witnessed the surge of cell-membrane-coated nanoparticles (CMNPs) as a promising intervention for osteoporosis, leveraging their distinct attributes including refined biocompatibility, heightened pharmaceutical payload capacity, as well as targeted drug release kinetics...
April 8, 2024: Nanoscale
https://read.qxmd.com/read/38584434/grey-water-footprint-for-evaluating-zefta-wastewater-treatment-plant-a-case-study
#28
JOURNAL ARTICLE
Sayed I Ahmed, Mohamed H Moustafa, Tarek S Metwaly, Hamdy M Shata, Yasmin E Elmesery, Said El-Dahy, Ahmed A Sirry, Mohamad A Al Azab, Farag A Samhan
The numbers of wastewater treatment plants (WWTP) in Egypt are increasing, yet the general level of pollution associated with wastewater discharge after treatment has not been evaluated. Grey water footprint (GWF) was used to assess the effluent discharges from Zefta WWTP. GWF, before and after treatment, was calculated and followed up to determine its impact on the receiving freshwater body. 150 samples were collected and analysed for BOD5 to determine the optimum operating conditions. Averages values were DO = 2...
April 7, 2024: Environmental Technology
https://read.qxmd.com/read/38583076/menopausal-hormone-therapy-and-risk-of-venous-thromboembolism-the-story-so-far
#29
REVIEW
Mohsen M A Abdelhafez, Karim A M Ahmed, Nashwa A M Ahmed, Mohd H Ismail, Mohd N M Daud, Aya M E Eldiasty, Mohd F B Amri, Mohammad S Jeffree, Fairrul K Masnah, Dg M P Baharuddin, Mohd F Bolong, Mohd F Hayati, Nornazirah B Azizan, Doreen Sumpat, Syed S S Abdul Rahim, Win W Than, Mohd Y Ibrahim, Zhen Z Lo, May Z Soe
Menopausal hormone therapy (MHT) is known to increase the risk of venous thromboembolism (VTE), which includes deep vein thrombosis, pulmonary embolism, and less frequently cerebral vein thrombosis, but the absolute risk for a given patient is very low. After starting MHT, the risk of VTE seems to be at its highest, declining to the non-HRT user baseline level of risk after stopping. Whether estrogen-only or estrogen-progestin HRT combination is linked to a similar risk of VTE is unclear from the available evidence...
March 31, 2024: African Journal of Reproductive Health
https://read.qxmd.com/read/38581982/biogas-upgrading-and-membrane-anti-fouling-mechanisms-in-electrochemical-anaerobic-membrane-bioreactor-ec-anmbr-focusing-on-spatio-temporal-distribution-of-metabolic-functionality-of-microorganisms
#30
JOURNAL ARTICLE
Yule Han, Wanjiang Li, Yijing Gao, Teng Cai, Jiayi Wang, Zhaobin Liu, Jian Yin, Xueqin Lu, Guangyin Zhen
Electrochemical anaerobic membrane bioreactor (EC-AnMBR) by integrating a composite anodic membrane (CAM), represents an effective method for promoting methanogenic performance and mitigating membrane fouling. However, the development and formation of electroactive biofilm on CAM, and the spatio-temporal distribution of key functional microorganisms, especially the degradation mechanism of organic pollutants in metabolic pathways were not well documented. In this work, two AnMBR systems (EC-AnMBR and traditional AnMBR) were constructed and operated to identify the role of CAM in metabolic pathway on biogas upgrading and mitigation of membrane fouling...
March 30, 2024: Water Research
https://read.qxmd.com/read/38581019/mesenchymal-stromal-cell-chondrogenesis-under-alk1-2-3-specific-bmp-inhibition-a-revision-of-the-prohypertrophic-signalling-network-concept
#31
JOURNAL ARTICLE
Solvig Diederichs, Simon I Dreher, Sarah Anna Nüesch, Sven Schmidt, Christian Merle, Wiltrud Richter
BACKGROUND: In vitro chondrogenesis of mesenchymal stromal cells (MSCs) driven by the essential chondro-inducer transforming growth factor (TGF)-β is instable and yields undesired hypertrophic cartilage predisposed to bone formation in vivo. TGF-β can non-canonically activate bone morphogenetic protein-associated ALK1/2/3 receptors. These have been accused of driving hypertrophic MSC misdifferentiation, but data remained conflicting. We here tested the antihypertrophic capacity of two highly specific ALK1/2/3 inhibitors - compound A (CompA) and LDN-212854 (LDN21) - in order to reveal potential prohypertrophic contributions of these BMP/non-canonical TGF-β receptors during MSC in vitro chondrogenesis...
April 5, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38580693/long-acting-growth-hormone-in-the-treatment-of-growth-hormone-deficiency-in-children-a-systematic-literature-review-and-network-meta-analysis
#32
JOURNAL ARTICLE
Jianfang Zhu, Ke Yuan, Sunita Rana, Satya Lavanya Jakki, Amit Subray Bhat, Li Liang, Chunlin Wang
The purpose of this study is to compare the relative efficacy and safety of long-acting growth hormone (LAGH) as a growth hormone replacement therapy in prepubertal children with growth hormone deficiency (GHD). We searched the PubMed, Embase, CNKI, and Wanfang databases from inception to July 2023 and identified eleven relevant studies. PEG-LAGH showed better effect on height velocity (mean difference [MD]: - 0.031, 95% credibility interval [CrI]: - 0.278, 0.215) than somatrogon (MD: 0...
April 5, 2024: Scientific Reports
https://read.qxmd.com/read/38578401/long-term-use-of-clomiphene-in-male-macroprolactinomas-with-persistent-hypogonadism
#33
JOURNAL ARTICLE
Matheo A M Stumpf, Stefano A Galliano, Cristina B F Bueno, Andrea Glezer
BACKGROUND: Men with macroprolactinoma can present persistent hypogonadism despite normoprolactinemia achieved with clinical and/or neurosurgical treatment. Usually, testosterone replacement therapy is indicated. Nevertheless, although off-label, clomiphene citrate (CC), a selective estrogen receptor modulator, has also been used, mainly when fertility is an issue. The aim of this study is to evaluate the effectiveness of CC in recovering the gonadal axis in men with macroprolactinoma, with or without hyperprolactinemia, and evaluate its safety as a long-term therapy...
April 5, 2024: Endocrine
https://read.qxmd.com/read/38577191/from-liver-to-hormones-the-endocrine-consequences-of-cirrhosis
#34
REVIEW
Juan Eduardo Quiroz-Aldave, Elman Rolando Gamarra-Osorio, María Del Carmen Durand-Vásquez, Luciana Del Pilar Rafael-Robles, Jhean Gabriel Gonzáles-Yovera, María Alejandra Quispe-Flores, Luis Alberto Concepción-Urteaga, Alejandro Román-González, José Paz-Ibarra, Marcio José Concepción-Zavaleta
Hepatocrinology explores the intricate relationship between liver function and the endocrine system. Chronic liver diseases such as liver cirrhosis can cause endocrine disorders due to toxin accumulation and protein synthesis disruption. Despite its importance, assessing endocrine issues in cirrhotic patients is frequently neglected. This article provides a comprehensive review of the epidemiology, pathophysiology, diagnosis, and treatment of endocrine disturbances in liver cirrhosis. The review was conducted using the PubMed/Medline, EMBASE, and Scielo databases, encompassing 172 articles...
March 7, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38575798/a-retrospective-study-of-ovarian-tissue-cryopreservation-in-female-patients-with-hematological-diseases-for-fertility-preservation
#35
JOURNAL ARTICLE
Yi-Ling Wang, Qing-Jie Zhai, Zhao-Hua Wang, Xin Yang, Jian-Liu Wang, Hong-Lan Zhu
PURPOSES: To investigate the effect and safety of ovarian tissue cryopreservation (OTC) for fertility preservation in female patients with hematological diseases. METHODS: We designed a retrospective study. The clinical data of patients with hematological diseases undergoing OTC admitted to Peking University People's Hospital from April 2017 to January 2023 were analyzed and summarized. RESULTS: A total of 24 patients were included in the study, including 19 patients with malignant hematological diseases and 5 patients with non-malignant hematological diseases...
April 4, 2024: Archives of Gynecology and Obstetrics
https://read.qxmd.com/read/38572627/fertility-outcomes-in-male-adults-with-congenital-hypogonadotropic-hypogonadism-treated-during-puberty-with-human-chorionic-gonadotropin-and-recombinant-follicle-stimulating-hormone
#36
JOURNAL ARTICLE
Francisca Grob, Rachna Keshwani, Eleanor Angley, Margaret Zacharin
AIM: Hormone replacement therapy with testosterone for pubertal induction in boys with congenital hypogonadotropic hypogonadism (CHH) achieves virilization but not spermatogenesis. By contrast, human chorionic gonadotropin (hCG) and recombinant follicle stimulating hormone (rFSH) provides both virilization and spermatogenesis. Fertility outcomes of boys treated with recombinant therapy during adolescence have been infrequently described. We report fertility induction and pregnancy outcomes in CHH patients treated with recombinant gonadotropins during puberty...
April 4, 2024: Journal of Paediatrics and Child Health
https://read.qxmd.com/read/38572533/treatment-of-hypoparathyroidism-by-re-establishing-the-effects-of-parathyroid-hormone
#37
JOURNAL ARTICLE
Lars Rejnmark
The conventional treatment of hypoparathyroidism (HypoPT) includes active vitamin D and calcium. Despite normalization of calcium levels, the conventional treatment is associated with fluctuations in calcium levels, hypercalciuria, renal impairment, and decreased quality of life (QoL). Replacement therapy with parathyroid hormone (PTH)(1-84) is an option in some countries. However, convincing beneficial effects have not been demonstrated, which may be due to the short duration of action of this treatment. Recently, palopegteriparatide (also known as TransCon PTH) has been marketed in Europe and is expected also to be approved in other countries...
April 4, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38571387/monitoring-adrenal-insufficiency-through-salivary-steroids-a-pilot-study
#38
JOURNAL ARTICLE
Lorenzo Tucci, Flaminia Fanelli, Ilaria Improta, Valentina Bissi, Claudia Lena, Greta Galante, Marco Mezzullo, Matteo Magagnoli, Anna Bianca Lalumera, Giacomo Colombin, Kimberly Coscia, Laura Rotolo, Valentina Vicennati, Uberto Pagotto, Guido Di Dalmazi
BACKGROUND: Various glucocorticoid replacement treatments (GRT) are available for adrenal insufficiency (AI). However, their effectiveness in restoring glucocorticoid rhythm and exposure lacks adequate biochemical markers. We described the diurnal salivary cortisol (SalF) and cortisone (SalE) rhythm among different GRTs and analysed the associations between saliva-derived parameters and life quality questionnaires. METHODS: Control subjects (CS, n=28) and AI patients receiving hydrocortisone (HC, n=9), cortisone acetate (CA, n=23), dual-release hydrocortisone once (DRHC-od, n=10) and twice a day (DRHC-td, n=6) collected 9 saliva samples from 07:00 to 23:00...
April 4, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38569956/meta-analysis-review-for-pilot-and-large-scale-constructed-wetlands-design-parameters-treatment-performance-and-influencing-factors
#39
REVIEW
Vinh Son Lam, Thi Cuc Phuong Tran, Thi-Dieu-Hien Vo, Dinh Duc Nguyen, Xuan Cuong Nguyen
Despite their longstanding use in environmental remediation, constructed wetlands (CWs) are still topical due to their sustainable and nature-based approach. While research and review publications have grown annually by 7.5 % and 37.6 %, respectively, from 2018 to 2022, a quantitative meta-analysis employing advanced statistics and machine learning to assess CWs has not yet been conducted. Further, traditional statistics of mean ± standard deviation could not convey the extent of confidence or uncertainty in results from CW studies...
April 1, 2024: Science of the Total Environment
https://read.qxmd.com/read/38567166/pituitary-adenoma-prevalence-and-characteristics-of-omani-patients-a-single-center-experience
#40
JOURNAL ARTICLE
Abdullah M Al Futaisi, Asma M Al Marzouqi, Mohammed A Al Abri, Maha Z Al Riyami
OBJECTIVES: To estimate the incidence of pituitary adenomas (PA) in adult Omani patients and describe its epidemiological, clinical, and radiological characteristics. METHODS: In this longitudinal, descriptive study, we reviewed the records of all PA patients from January 2015 to January 2020 who presented at the endocrinology facilities at Sultan Qaboos University Hospital, Muscat. RESULTS: The participants comprised of 112 Omani patients with PA...
January 2024: Oman Medical Journal
keyword
keyword
48839
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.